Drug search by name

Antihemophilic Factor/VWF Complex (Human) and Cardiovascular complications

Result of checking the interaction of drug Antihemophilic Factor/VWF Complex (Human) and disease Cardiovascular complications for safety when used together.

Check result:

Antihemophilic Factor/VWF Complex (Human) <> Cardiovascular complications

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hemophilic patients with cardiovascular risk factors or diseases may be at the same risk to develop cardiovascular events as non-hemophilic patients when clotting has been normalized by treatment with factor VIII. Care should be exercised when using this agent in patients with cardiovascular risk factors.

Antihemophilic Factor/VWF Complex (Human)

Generic Name: antihemophilic factor / von willebrand factor

Brand Name: Alphanate, Humate-P, Wilate, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate

Synonyms: Antihemophilic and von Willebrand factor complex, Antihemophilic Factor/von Willebrand Factor Complex (Human)

What is Antihemophilic Factor/VWF Complex (Human)?